Carbone Cancer Center / University of Wisconsin — Madison, Wisconsin

Carbone Cancer Center / University of Wisconsin is a clinical research site located in Madison, Wisconsin, United States 53792.

Crixeo Clinical Trials Trust Score: 93/100 (GOOD). This profile has not yet been claimed by the site owner.

Carbone Cancer Center / University of Wisconsin has participated in 8 clinical trials with 1 currently active.

Therapeutic areas: Hodgkin Disease, Peripheral T Cell Lymphoma, Non-small Cell Lung Cancer.

Sponsors: Seagen Inc., Seagen, a wholly owned subsidiary of Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Madison

Browse all research sites in Wisconsin · View every site in Madison

Sponsor Feasibility Report

Trust Score: 93/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Carbone Cancer Center / University of Wisconsin?

Carbone Cancer Center / University of Wisconsin has a Crixeo Trust Score of 93/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Carbone Cancer Center / University of Wisconsin conducted?

Carbone Cancer Center / University of Wisconsin has 8 clinical trials on record, with 1 currently active. Their work covers Hodgkin Disease, Peripheral T Cell Lymphoma, Non-small Cell Lung Cancer.

Is Carbone Cancer Center / University of Wisconsin accredited by Crixeo Clinical Trials?

Carbone Cancer Center / University of Wisconsin has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Carbone Cancer Center / University of Wisconsin?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.